LEVEL

Serial Number 97648766
606

Registration Progress

Application Filed
Oct 26, 2022
Under Examination
Oct 31, 2023
Approved for Publication
Sep 5, 2023
Published for Opposition
Sep 5, 2023
Registered

Trademark Image

LEVEL

Basic Information

Serial Number
97648766
Filing Date
October 26, 2022
Published for Opposition
September 5, 2023
Abandonment Date
December 2, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 2, 2024
Classes
042

Rights Holder

ACORDA THERAPEUTICS, INC.

03
Address
2 Blue Hill Plaza, 3rd Flr
Pearl River, NY 10965

Ownership History

ACORDA THERAPEUTICS, INC.

Original Applicant
03
Pearl River, NY

ACORDA THERAPEUTICS, INC.

Owner at Publication
03
Pearl River, NY

Legal Representation

Attorney
Joseph C. Guagliardo

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description Documents
Dec 2, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 2, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Apr 30, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 29, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 29, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 29, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 31, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 5, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 5, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 16, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 29, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 25, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 31, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 29, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Providing medical and scientific research information in the field of clinical trials for pharmaceuticals used in the treatment of neurological diseases, disorders and conditions in patients

Classification

International Classes
042